New Breakthrough in Cancer Immunotherapy!

[Neoepitope Discovery Boosts Cancer Immunotherapy Development]

Scientists have utilized mass spectrometry technology to discover tumor-specific "neoepitopes." This discovery is expected to significantly contribute to the development of personalized cancer immunotherapies.

Key Data:

• Capability to detect protein fragments at extremely low concentrations.
• Requires only a minimal amount of samples for analysis.
• Helps accelerate the progress of cancer immunotherapy.

For more details, please visit: https://tinyurl.com/2azkvrsp

Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).

Figure 1

Figure 2

Figure 3

Figure 4